Related Experiment Videos

Bone marrow architecture in acute myeloid/erythroid leukaemia

Scott M McCloskey¹, Mary F McMullin, Treen C M Morris

¹Department of Haematology, Belfast City Hospital, Belfast, UK. scott.mccloskey@bll.n-i.nhs.uk

British Journal of Haematology

|June 17, 2004

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.

Nature communications·2023

Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies.

Cancer medicine·2023

A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia: Results from the LI-1 trial.

British journal of haematology·2022

Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study.

Bone marrow transplantation·2022

MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic.

Future oncology (London, England)·2021

Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort.

Journal of clinical pathology·2020

See all related articles